BRAINAURORA-B (06681) released its performance for 2025, with a net loss attributable to shareholders of 315 million yuan, a 58.8% increase from the previous year.

BRAINAURORA-B (06681) released its performance for the year ending December 31, 2025, with revenue of 220 million yuan, a year-on-year increase of 79.91%; the company's attributable loss to owners expanded by 58.8% to 315 million yuan, with a basic loss per share of 0.27 yuan. The increase in revenue during the period was mainly due to (i) the number of hospitals that had established formal cooperation relationships by the end of 2025 increased to 206. These cooperating hospitals are widely distributed, mainly concentrated in the Pearl River Delta, Beijing-Tianjin-Hebei, Sichuan, Henan, and other regions, gradually covering central and northern core cities, laying a solid channel foundation for the nationwide scaled application of products; (ii) on the user end, core operating indicators achieved comprehensive improvement: (1) the number of times patients used the company's system increased from about 1.8 million times in 2024 to about 3.3 million times by the end of 2025; (2) the average monthly active users increased from 2154.67 people in 2024 to 4290.75 people in 2025, a growth rate of 99.14%; (3) the monthly active users reached 10,229 in December 2025, a 72.52% increase from 5929 in the same period of 2024; (4) the average daily usage time of users in 2025 was 23.29 minutes, reflecting strong user stickiness and intervention compliance; (iii) sales of medical AI large language model solutions added revenue of 49.78 million yuan.